More extensive nodal dissection improves survival for stages I to III of colon cancer: A population-based study

Annals of Surgery

Volumn 244, Issue 4, 2006, Pages 602-608

  Chen, Steven L ^a   Bilchik, Anton J ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; CORRELATION ANALYSIS; DEMOGRAPHY; EARLY CANCER; FEMALE; GENDER; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; REGRESSION ANALYSIS; TUMOR VOLUME;

AGED; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; SURVIVAL RATE;

EID: 33748944356     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000237655.11717.50     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2006. CA Cancer J Clin. 2006;56:106-130.
2. MacDonald JS. Adjuvant therapy of colon cancer. CA Cancer J Clin. 1999;49:202-219.
3. Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
4. Prandi M, Lionetto R, Bini A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235:458-463.
5. Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76:1165-1167.
6. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of Intergroup trial INT-0089. J Clin Oncol. 2003;21:2912-2919.
7. Joseph NE, Sigurdson ER, Hanlon AL, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol. 2003;10:213-218.
8. Maurel J, Launoy G, Grosclaude P, et al. Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer. 2000;82:1482-1486.
9. Fielding LP, Aresnault PA, Chapuis PH, et al. Working party report to the World Congress of Gastroenterology, Sydney 1990. J Gastroenterol Hepatol. 1991;6:325-344.
10. Wong JH, Severino R, Honnebier MB, et al. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol. 1999;17:2896-2900.
11. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med. 2000;124:979-994.
12. Goldstein NS, Weldon S, Coffey M, et al. Lymph node recovery from colorectal resection specimens removed from adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol. 1996;106:209-216.
13. André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343-2351.
14. Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based Study. J Natl Cancer Inst. 2005;95:219-225.
15. National Cancer Institute. Overview of the SEER Program. Available on the World Wide Web at http://seer.cancer.gov/about/. Accessed March 29, 2006.
16. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual, 6th ed, New York: Springer-Verlag, 2002.
17. Kaplan E, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457-481.
18. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
19. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93:583-596.
20. Wright FC, Law CHL, Last L, et al. Lymph node retrieval and assessment in stage II colorectal cancer: a population based study. Ann Surg Oncol. 2003;10:903-909.
21. Reinbach DH, McGregor JR, Murray GD, et al. Effect of the surgeon's specialty interest on the type of resection performed for colorectal cancer. Dis Colon Rectum. 1994;37:1020-1023.
22. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendation on minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26:179-189.
23. Wong JH, Johnson DS, Hemmings D, et al. Assessing the quality of colorectal cancer staging: documenting the process in improving the staging of node-negative colorectal cancer. Arch Surg. 2005;140:881-887.
24. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
25. Enker WE, Thaler HT, Cranor ML, et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181:335-346.
26. Truong PT, Berthelet E, Lee J, et al. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary nodes. Cancer. 2005;103:2006-2014.
27. van der Wal BC, Butzelaar RM, van der Meij S, et al. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol. 2002;28:481-489.
28. Kim J, Cheong JH, Hyung WJ, et al. Predictors of long-term survival in pN3 gastric cancer patients. J Surg Oncol. 2004;88:9-13.
29. Rodriguez Santiago JM, Munoz E, Marti M, et al. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol. 2005;31:59-66.
30. Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706-8712.
31. Jessup JM, Stewart A, Greene FL, et al. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294:2703-2711.
32. Schrag D, Cramer LD, Bach PB, et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93:850-857.
33. Schrag D, Rifas-Shiman S, Saltz L, et al. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol. 2002;20:3999-4005.
34. National Cancer Database. Stage/treatment of colon cancer diagnosed in 2000. Available on the World Wide Web at http://web.facs.org/ncdbbmr/frames/ public7/TABLES/Y00S14XaTa_15190000_Tb_B.html Accessed March 28, 2006.
35. Haboubi NY, Clark P, Kaftan SM, et al. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med. 1992;85:386-388.